Sincerity is Good PR
The first thing to say about this story is that the headline--"Are GlaxoSmithKline's Do-Gooder Moves Genuine or Just Good PR?"--is extremely annoying. If GSK's "do-gooder" moves are good PR, they are genuine; if they are not genuine, they are by definition bad PR.
The rest of the article, however, is a decent overview of corporate responsibility activities at GSK since Andrew Witty took over as chief executive a couple of years ago.
Witty "made changes at GSK relating to policy and ethics, such as voluntarily stopping all corporate political contributions worldwide. He also capped payments to doctors and published a list of fees paid to U.S. health care professionals."
The article's fence-straddling conclusion: "So, perhaps his efforts are legit."
There are no comments for this entry.
[Add Comment]